Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Schönborn I[au]:

Expression of E-cadherin/catenin complexes in breast cancer. Schonborn I et al. Int J Oncol. (1997)

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Reles A et al. Clin Cancer Res. (2001)

[Hormonal contraception and the risk of cancer]. Ebeling K et al. Z Arztl Fortbild (Jena). (1990)

Search results

Items: 25

1.

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.

Reles A, Wen WH, Schmider A, Gee C, Runnebaum IB, Kilian U, Jones LA, El-Naggar A, Minguillon C, Schönborn I, Reich O, Kreienberg R, Lichtenegger W, Press MF.

Clin Cancer Res. 2001 Oct;7(10):2984-97.

2.

Asynchronous chromosome pairing in male meiosis of the rat (Rattus norvegicus).

Scherthan H, Schönborn I.

Chromosome Res. 2001;9(4):273-82.

PMID:
11419792
3.

Expression of E-cadherin/catenin complexes in breast cancer.

Schonborn I, Zschiesche W, Behrens J, Herrenknecht K, Birchmeier W.

Int J Oncol. 1997 Dec;11(6):1327-34.

PMID:
21528342
4.

Expression of E-cadherin and catenins in invasive mammary carcinomas.

Zschiesche W, Schönborn I, Behrens J, Herrenknecht K, Hartveit F, Lilleng P, Birchmeier W.

Anticancer Res. 1997 Jan-Feb;17(1B):561-7.

PMID:
9066580
5.

[Significance of PCNA proliferating fraction for prognosis of ovarian carcinoma].

Schönborn I, Minguillon C, Reles A, Bartel U, Lichtenegger W.

Geburtshilfe Frauenheilkd. 1996 Jul;56(7):357-64. German.

PMID:
8964450
6.

[C-erbB-2, PCNA and histomorphologic factors in breast carcinoma after oral contraceptive use].

Schönborn I, Minguillon C, Zschiesche W, Möhner M, Ebeling K.

Pathologe. 1996 May;17(3):202-7. German.

PMID:
8710791
7.

EGF-R and PCNA expression in ovarian carcinomas--correlation with classic prognostic factors.

Minguillon C, Schönborn I, Reles A, Bartel U, Lichtenegger W.

Gen Diagn Pathol. 1996 Mar;141(3-4):197-201.

PMID:
8705783
8.

Immunostaining of p53 protein in ovarian carcinoma: correlation with histopathological data and clinical outcome.

Reles A, Schmider A, Press MF, Schönborn I, Friedmann W, Huber-Schumacher S, Strohmeyer T, Lichtenegger W.

J Cancer Res Clin Oncol. 1996;122(8):489-94.

PMID:
8698749
9.

[C-erbB-2, EGF receptor, p53 and PCNA. The prognostic significance of recent tumor markers for lymph node negative breast cancer].

Schönborn I, Minguillon C, Lichtenegger W, Zschiesche W, Spitzer E.

Geburtshilfe Frauenheilkd. 1995 Oct;55(10):566-71. German.

PMID:
8543129
10.

[Overexpression of p53 protein in ovarian carcinomas: correlation with histopathologic data and clinical course].

Reles A, Press MF, Schönborn I, Lichtenegger W, Strohmeyer T.

Gynakol Geburtshilfliche Rundsch. 1995;35 Suppl 1:93-7. German.

PMID:
8672936
11.

Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer.

Schönborn I, Zschiesche W, Minguillon C, Spitzer E, Möhner M, Ebeling K, Grosse R.

J Cancer Res Clin Oncol. 1995;121(2):115-22.

PMID:
7883773
12.

[Gestational trophoblastic tumors--a report of experiences].

Ebeling K, Schönborn I, Johannsmeyer D.

Zentralbl Gynakol. 1995;117(5):237-42. German.

PMID:
7540787
13.

[Does previous exposure to oral contraceptives modify survival in breast cancer?].

Schönborn I, Ebeling K, Nischan P.

Geburtshilfe Frauenheilkd. 1994 Oct;54(10):559-63. German.

PMID:
8001752
14.

[Gestational trophoblast tumors--rare, but important in general practice].

Ebeling K, Schönborn I, Johannsmeyer D.

Z Arztl Fortbild (Jena). 1994 Oct;88(10):773-8. Review. German. No abstract available.

PMID:
7529957
15.

Significance of immunohistochemical c-erbB-2 product localization pattern for prognosis of primary human breast cancer.

Zschiesche W, Schönborn I, Minguillon C, Spitzer E.

Cancer Lett. 1994 Jun 15;81(1):89-94.

PMID:
7912648
16.

Oral contraceptive use and the prognosis of breast cancer.

Schönborn I, Nischan P, Ebeling K.

Breast Cancer Res Treat. 1994;30(3):283-92.

PMID:
7981446
17.

[Effect of oral contraceptives on the proliferative activity of breast cancer].

Schönborn I, Minguillon C, Möhner M.

Zentralbl Gynakol. 1994;116(7):385-9. German.

PMID:
7941803
18.

C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk.

Schönborn I, Zschiesche W, Spitzer E, Minguillon C, Möhner M, Ebeling K, Grosse R.

Breast Cancer Res Treat. 1994;29(3):287-95.

PMID:
7914107
19.

[Importance of PCNA proliferating fraction and histomorphologic prognostic factors for survival in breast cancer].

Schönborn I, Minguillon C, Möhner M, Ebeling K.

Pathologe. 1993 Dec;14(6):307-12. German. No abstract available.

PMID:
7907179
20.

[Continuous ambulatory intravenous morphine infusion for pain therapy in advanced ovarian cancer].

Sorge J, Schönborn I, Günter HH, Steffmann B, Hilfrich J, Kühnle H.

Geburtshilfe Frauenheilkd. 1992 May;52(5):304-6. German.

PMID:
1377150
21.

[Biofreezer BF 80--a universally employed apparatus in preservation at very low temperatures].

Küster U, Kunert M, Schönborn I, Weber P, Heyer G, Mansfeld HW, Ittenson A, Ansorge S.

Z Med Lab Diagn. 1991;32(3-4):204-8. German.

PMID:
1897300
22.

[Hormonal contraception and the risk of cancer].

Ebeling K, Schönborn I.

Z Arztl Fortbild (Jena). 1990;84(1-2):59-63. Review. German. No abstract available.

PMID:
2184603
23.

[Effect of administration of hormonal contraceptives on prognostic factors in breast cancer].

Schönborn I, Ebeling K.

Zentralbl Gynakol. 1990;112(5):263-6. German.

PMID:
2162121
24.

["Airway occlusion technique for the diagnosis of lung function in premature and newborn infants"].

Kunert M, Schönborn I, Mäder G, Lamme W.

Biomed Tech (Berl). 1990;35 Suppl 3:307-9. German. No abstract available.

PMID:
2078748

Supplemental Content

Loading ...
Support Center